tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Julie Mead, 1 are a SELL (33.33%), 2 are a HOLD (66.67%).
Analyst Julie Mead works at HSBC
Julie Mead’s has documented 5 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AZN, AstraZeneca PLC ADR at 15-Oct-2021.
Analyst best performing recommendations are on AZN (ASTRAZENECA PLC ADR).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
82
$5.65 (7.40%)
80
10 days ago
0/4 (0%)
$6.83 (9.09%)
Hold
2 months 28 days ago
0/11 (0%)
$82.61 (131.40%)
Buy
85
$8.65 (11.33%)
3 months 13 days ago
0/11 (0%)
$19.26 (29.30%)
Hold
70
$-6.35 (-8.32%)
4 months 3 days ago
5/5 (100%)
$2.71 (4.03%)
224
Buy
142.74
9 months 24 days ago
0/6 (0%)
$75.62 (112.66%)
What Year was the first public recommendation made by Julie Mead?
